Invention Grant
- Patent Title: Substituted 6,5-fused bicyclic heteroaryl compounds
-
Application No.: US15492506Application Date: 2017-04-20
-
Publication No.: US10273223B2Publication Date: 2019-04-30
- Inventor: Kevin Wayne Kuntz , Edward James Olhava , Richard Chesworth , Kenneth William Duncan
- Applicant: Epizyme, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Epizyme, Inc.
- Current Assignee: Epizyme, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Cooley LLP
- Agent Heidi A. Erlacher; Xixi Sun
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D471/04 ; C07D401/04 ; C07D401/14 ; C07D405/14 ; C07D413/14 ; A61P35/00
Abstract:
The present invention relates to substituted 6,5-fused bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof.
Public/Granted literature
- US20180072702A1 SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS Public/Granted day:2018-03-15
Information query
